326 related articles for article (PubMed ID: 23255114)
41. A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor.
Sawatsubashi S; Murata T; Lim J; Fujiki R; Ito S; Suzuki E; Tanabe M; Zhao Y; Kimura S; Fujiyama S; Ueda T; Umetsu D; Ito T; Takeyama K; Kato S
Genes Dev; 2010 Jan; 24(2):159-70. PubMed ID: 20040570
[TBL] [Abstract][Full Text] [Related]
42. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.
Wise-Draper TM; Allen HV; Jones EE; Habash KB; Matsuo H; Wells SI
Mol Cell Biol; 2006 Oct; 26(20):7506-19. PubMed ID: 16894028
[TBL] [Abstract][Full Text] [Related]
43. In silico gene expression and pathway analysis of DEK in the human brain across the lifespan.
Greene AN; Nguyen ET; Paranjpe A; Lane A; Privette Vinnedge LM; Solomon MB
Eur J Neurosci; 2022 Sep; 56(6):4720-4743. PubMed ID: 35972263
[TBL] [Abstract][Full Text] [Related]
44. The human DEK oncogene regulates DNA damage response signaling and repair.
Kavanaugh GM; Wise-Draper TM; Morreale RJ; Morrison MA; Gole B; Schwemberger S; Tichy ED; Lu L; Babcock GF; Wells JM; Drissi R; Bissler JJ; Stambrook PJ; Andreassen PR; Wiesmüller L; Wells SI
Nucleic Acids Res; 2011 Sep; 39(17):7465-76. PubMed ID: 21653549
[TBL] [Abstract][Full Text] [Related]
45. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141.
Liu CS; Zhou Q; Zhang YD; Fu Y
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2368-2379. PubMed ID: 32196588
[TBL] [Abstract][Full Text] [Related]
47. Progress in studies on the DEK protein and its involvement in cellular apoptosis.
Hua Y; Hu H; Peng X
Sci China C Life Sci; 2009 Jul; 52(7):637-42. PubMed ID: 19641868
[TBL] [Abstract][Full Text] [Related]
48. Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes.
Hu HG; Illges H; Gruss C; Knippers R
Int Immunol; 2005 Jun; 17(6):789-96. PubMed ID: 15908448
[TBL] [Abstract][Full Text] [Related]
49. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
50. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
51. Dek Modulates Global Intron Retention during Muscle Stem Cells Quiescence Exit.
Yue L; Wan R; Luan S; Zeng W; Cheung TH
Dev Cell; 2020 Jun; 53(6):661-676.e6. PubMed ID: 32502396
[TBL] [Abstract][Full Text] [Related]
52. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.
Kappes F; Waldmann T; Mathew V; Yu J; Zhang L; Khodadoust MS; Chinnaiyan AM; Luger K; Erhardt S; Schneider R; Markovitz DM
Genes Dev; 2011 Apr; 25(7):673-8. PubMed ID: 21460035
[TBL] [Abstract][Full Text] [Related]
53. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
Mor-Vaknin N; Saha A; Legendre M; Carmona-Rivera C; Amin MA; Rabquer BJ; Gonzales-Hernandez MJ; Jorns J; Mohan S; Yalavarthi S; Pai DA; Angevine K; Almburg SJ; Knight JS; Adams BS; Koch AE; Fox DA; Engelke DR; Kaplan MJ; Markovitz DM
Nat Commun; 2017 Feb; 8():14252. PubMed ID: 28165452
[TBL] [Abstract][Full Text] [Related]
54. DEK Expression is controlled by E2F and deregulated in diverse tumor types.
Carro MS; Spiga FM; Quarto M; Di Ninni V; Volorio S; Alcalay M; Müller H
Cell Cycle; 2006 Jun; 5(11):1202-7. PubMed ID: 16721057
[TBL] [Abstract][Full Text] [Related]
55. Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia.
O'Donovan SM; Franco-Villanueva A; Ghisays V; Caldwell JL; Haroutunian V; Privette Vinnedge LM; McCullumsmith RE; Solomon MB
Schizophr Res; 2018 Dec; 202():188-194. PubMed ID: 30017458
[TBL] [Abstract][Full Text] [Related]
56. The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.
Waldmann T; Scholten I; Kappes F; Hu HG; Knippers R
Gene; 2004 Dec; 343(1):1-9. PubMed ID: 15563827
[TBL] [Abstract][Full Text] [Related]
57. DEK expression in melanocytic lesions.
Kappes F; Khodadoust MS; Yu L; Kim DS; Fullen DR; Markovitz DM; Ma L
Hum Pathol; 2011 Jul; 42(7):932-8. PubMed ID: 21316078
[TBL] [Abstract][Full Text] [Related]
58. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract][Full Text] [Related]
59. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
60. The SAF-box domain of chromatin protein DEK.
Böhm F; Kappes F; Scholten I; Richter N; Matsuo H; Knippers R; Waldmann T
Nucleic Acids Res; 2005; 33(3):1101-10. PubMed ID: 15722484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]